The forum will feature 20-minute presentations (including Q&A) from a curated selection of exciting start-up companies, all carefully selected through our screening processes. You will also see updated presentations from past presenting companies.
Personalized Stem Cells (PSC) is pioneering personalized medicine through innovative stem cell therapies for osteoarthritis. With decades of expertise, advanced FDA-compliant technology, and a clear path to commercialization, revenue generating biobanking, PSC offers a unique investment opportunity in a $400B market with immense growth potential.
TUSK is a free speech-focused browser and search engine with privacy features, avoiding censorship. It’s gaining traction with 65K users and has significant market potential of over 100M due to very little competition focused on Conservatives. Fully built and running, they need funds to maintain and scale marketing.
Faradai has clients in 42 countries including Fortune 500 companies such as Coca Cola, Shell, CBRE, Pepsico, IKEA, Tetrapak, Vodafone, Turkish Airlines, Zara. Faradai raised $4.5M from SIlicon Valley, UK, Switzerland, Dubai and Singapore based VCs.
Founded out of Stanford University, Rejuvenation Technologies seeks to transform medicine by reversing the aging process to cure disease and extend the human health span and lifespan by two to three decades. The core technology is an RNA lipid nanoparticle delivered to targeted tissues and cell types throughout the body.